Literature DB >> 7545836

Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation.

A B Jain1, A Pinna, J J Fung, V Warty, A K Singhal, J Lever, R Venkataramanan.   

Abstract

Tacrolimus has been found to be useful in clinical solid organ transplantation. A very careful monitoring of the tacrolimus levels and dose adjustments are essential, at least in the immediate post-liver transplantation, situation. However, quite often after liver transplantation, patients have limited venous access for daily monitoring of tacrolimus levels. When the blood is sampled from a multilumen central venous catheter, used also for intravenous administration of tacrolimus, falsely elevated concentrations of tacrolimus have been observed. The present study examines the concentration of tacrolimus in capillary blood samples obtained from finger stick and compares its concentrations in simultaneously drawn samples from arterial line, peripheral venous puncture, and multilumen centrally placed venous catheter from the port used for tacrolimus infusion and the port not used for tacrolimus infusion. Ten adult post-liver transplantation recipients were studied. Whole blood concentration of tacrolimus in capillary blood was comparable to that of arterial blood, as well as to that of peripheral venous blood samples (r2 = 0.99; P = 0.72). Concentrations of tacrolimus in venous blood drawn from the port of the multilumen catheter used for intravenous tacrolimus infusion were 3-23 times higher (P = 0.0015), while the concentrations of venous blood drawn from the port not used for tacrolimus infusion were 1.7-4.5 times higher (P = 0.016), as compared with arterial, capillary, or peripheral venous whole blood concentrations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545836     DOI: 10.1097/00007890-199509000-00020

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.

Authors:  S R Katari; M Magnone; R Shapiro; M Jordan; V Scantlebury; C Vivas; A Gritsch; J McCauley; T Starzl; A J Demetris; P S Randhawa
Journal:  Clin Transplant       Date:  1997-06       Impact factor: 2.863

Review 2.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

Review 3.  Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients.

Authors:  Amelia R Cossart; Nicole M Isbel; Carla Scuderi; Scott B Campbell; Christine E Staatz
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

4.  Temporary Parenteral Tacrolimus Requirement due to Unexplained Low Through Levels in a Liver Transplant Patient with Short Bowel Syndrome.

Authors:  V Ince; F Ozdemir; B Isik; M Yilmaz; C Kayaalp; S Yilmaz
Journal:  Int J Organ Transplant Med       Date:  2014
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.